Dr Cohra Colleen Mankey, MD | |
830 S Gloster St, Pathology Dept, Tupelo, MS 38801-4934 | |
(662) 620-7102 | |
(662) 620-7106 |
Full Name | Dr Cohra Colleen Mankey |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 830 S Gloster St, Tupelo, Mississippi |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093838799 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 21582 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Cohra Colleen Mankey, MD Po Box 1507, Tupelo, MS 38802-1507 Ph: (662) 620-7102 | Dr Cohra Colleen Mankey, MD 830 S Gloster St, Pathology Dept, Tupelo, MS 38801-4934 Ph: (662) 620-7102 |
News Archive
The development of common diabetes complications that can lead to blindness and amputations could be reduced by taking statins, indicates new research published in The Lancet Diabetes & Endocrinology.
What do particle diffusion in liquids and stock price prediction have to do with building a better HIV vaccine? According to University of Iowa microbiologist Hillel Haim, you can apply concepts from the first two to predict the evolution of HIV surface proteins, information that can then be used to design better vaccines.
Diabetes is on the rise. The seventh leading cause of death in the U.S. today, it affects 24 million people, nearly 3 times the number in 1980. Another 57 million have a condition that puts them at heightened risk of the illness.
A new method for detecting abnormalities in unborn children is providing physicians with more information to analyze the results than conventional, microscopic testing, according to two George Washington University researchers.
Researchers at The Medicines Company presented data from a multi-national cohort that demonstrates the mortality and morbidity, and poor outcomes, associated with current therapies in patients with infections due to carbapenem-resistant Enterobacteriaceae (CRE). The data from this analysis has guided the design of the company's on-going clinical studies of its Phase 3 compound, CARBAVANCE® (meropenem/RPX7009) and was presented at the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and the International Congress of Chemotherapy and Infection (ICC) joint meeting in San Diego, CA.
› Verified 1 days ago
Dr. Richard Dwight Griswold, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 830 S Gloster St, Pathology Department, Tupelo, MS 38801 Phone: 662-377-3000 | |
Dr. Frances Jariel Hairston, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 830 S Gloster St, Pathology Department, Tupelo, MS 38801 Phone: 662-377-3000 | |
Dr. Curtis Lynn Collins, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 830 S Gloster St, Pathology Department, Tupelo, MS 38801 Phone: 662-377-3000 | |
Harold Edward Sightler, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 830 S Gloster St, Pathology Dept, Tupelo, MS 38801 Phone: 662-620-1468 | |
Lulin Hu, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 830 S Gloster St, Tupelo, MS 38801 Phone: 662-377-3000 Fax: 419-866-5453 | |
Dr. Jerry Pascall Moore, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 146 Road 83, Tupelo, MS 38801 Phone: 662-407-0199 |